Company registration number 01432297 (England and Wales)
PRAMAC-GENERAC UK LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PRAMAC-GENERAC UK LIMITED
COMPANY INFORMATION
DIRECTORS
P Verriere
N Borracchini
(Appointed 30 June 2026)
J McNally
(Appointed 30 June 2026)
A Rossi
(Appointed 10 July 2026)
SECRETARY
Mr A N Coughlan
COMPANY NUMBER
01432297
REGISTERED OFFICE
Units 3 & 4 Nyfield Business Park
Lawford Road
Rugby
Warwickshire
CV21 2UX
AUDITOR
Kilsby & Williams LLP
Cedar House
Hazell Drive
Newport
South Wales
NP10 8FY
PRAMAC-GENERAC UK LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 9
Profit and loss account
10
Statement of comprehensive income
11
Balance sheet
12 - 13
Statement of changes in equity
14
Notes to the financial statements
15 - 31
PRAMAC-GENERAC UK LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The directors present the strategic report for the year ended 31 December 2025.

REVIEW OF THE BUSINESS

During the year, although the UK market has been characterized by cautious spending, selective capital investment and ongoing cost sensitivity, Pramac-Generac UK continued adapting to it, aligning its cost, strengthening internal processes and supporting customers with tailed support.

Management continued to invest in systems, service capability and operational efficiency initiatives to strengthen the Company’s long-term competitiveness and operational resilience. These investments were focused on enhancing internal processes, improving service delivery standards, and supporting scalability across the business. By reinforcing technological infrastructure, optimizing operational performance and developing organizational capabilities, Management aims to position the Company to better capture future growth opportunities, respond effectively to evolving market conditions, and create sustainable value over the long term.

The whole UK market remained highly influenced by companies’ elevated operating costs, ongoing pricing pressure and a prudent approach to capital expenditure. Although of a gradual stabilization in parts of the industrial sector, customers continued to prioritize price flexibility and service reliability.

Despite these conditions, Pramac-Generac UK strengthened its key strategic relationships and engaged with new customers to reposition itself within the UK market.

 

PRINCIPAL RISKS AND UNCERTAINTIES

The highly price-driven market has represented in 2025 an interesting obstacle and opportunity for the company. Key risks correlated have been the customer demand variability and competitive price policy adopted by competitors. Inflation and all other broader impacts of macro-economic uncertainty on impacting the industry sector.

 

The Directors consider that maintaining disciplined cost management and continued focus on customer service are important factors in mitigating these risks and supporting the Pramac performance over the long term.

KEY PERFORMANCE INDICATORS

The turnover increased by 14.57% compared to 2024 and the Gross Margin declined by 6.5% compared to 2024.

 

This performance, combined with the increase in the headcount and the development of new partnerships, is expected to support the growth of Pramac-Generac UK for the coming years.

 

PRAMAC-GENERAC UK LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -

On behalf of the board

J McNally
Director
11 August 2026
PRAMAC-GENERAC UK LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2025.

PRINCIPAL ACTIVITIES

The principal activity of the company continued to be that of selling generators and related components

RESULTS AND DIVIDENDS

The results for the year are set out on page 10.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

DIRECTORS

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

P Campinoti
(Resigned 30 June 2026)
N Pagliai
(Resigned 30 June 2026)
P Verriere
Mr J J Wright
(Resigned 20 June 2025)
N Borracchini
(Appointed 30 June 2026)
J McNally
(Appointed 30 June 2026)
A Rossi
(Appointed 10 July 2026)
STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

PRAMAC-GENERAC UK LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
STATEMENT OF DISCLOSURE TO AUDITOR

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

MEDIUM-SIZED COMPANIES EXEMPTION

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
J McNally
Director
11 August 2026
PRAMAC-GENERAC UK LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PRAMAC-GENERAC UK LIMITED
- 5 -
Opinion

We have audited the financial statements of Pramac-Generac UK Limited (the 'company') for the year ended 31 December 2025 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

PRAMAC-GENERAC UK LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PRAMAC-GENERAC UK LIMITED (CONTINUED)
- 6 -

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

PRAMAC-GENERAC UK LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PRAMAC-GENERAC UK LIMITED (CONTINUED)
- 7 -
Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates, and considered the risk of acts by the company that were contrary to applicable laws and regulations, including fraud. We designed audit procedures to respond to the risk, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.
We focussed on laws and regulations which could give rise to a material misstatement in the financial statements, including, but not limited to, the Companies Act 2006 and UK tax legislation. Our tests included agreeing the financial statement disclosures to underlying supporting documentation, enquiries with management and enquiries of legal counsel. There are inherent limitations in the audit procedures described above and, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. We did not identify any key audit matters relating to irregularities, including fraud. As in all our audits, we also addressed the risk of management override of internal controls, including testing journals and evaluating whether there was evidence of bias by the directors that represented a risk of material misstatement due to fraud.
PRAMAC-GENERAC UK LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PRAMAC-GENERAC UK LIMITED (CONTINUED)
- 8 -
As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the company to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

PRAMAC-GENERAC UK LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PRAMAC-GENERAC UK LIMITED (CONTINUED)
- 9 -
Simon Tee
Senior Statutory Auditor
For and on behalf of
Kilsby & Williams LLP
Chartered accountants & statutory auditor
Cedar House
Hazell Drive
Newport
South Wales
NP10 8FY
17 August 2026
PRAMAC-GENERAC UK LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
2025
2024
Notes
£
£
TURNOVER
3
29,303,538
25,576,083
Cost of sales
(22,994,482)
(18,561,589)
GROSS PROFIT
6,309,056
7,014,494
Distribution costs
(1,731,869)
(1,602,712)
Administrative expenses
(8,368,988)
(8,964,293)
Other operating income
1,309,622
333,859
OPERATING LOSS
5
(2,482,179)
(3,218,652)
Interest receivable and similar income
8
226,449
217,635
Interest payable and similar expenses
9
(979,743)
(781,376)
LOSS BEFORE TAXATION
(3,235,473)
(3,782,393)
Tax on loss
10
(48,578)
146,838
LOSS FOR THE FINANCIAL YEAR
(3,284,051)
(3,635,555)

The profit and loss account has been prepared on the basis that all operations are continuing operations.

PRAMAC-GENERAC UK LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
2025
2024
£
£
LOSS FOR THE YEAR
(3,284,051)
(3,635,555)
OTHER COMPREHENSIVE INCOME
-
-
TOTAL COMPREHENSIVE INCOME FOR THE YEAR
(3,284,051)
(3,635,555)
PRAMAC-GENERAC UK LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 12 -
2025
2024
Notes
£
£
FIXED ASSETS
Goodwill
11
15,870,079
18,448,838
Tangible assets
12
736,981
937,368
Investments
13
10,438,090
10,438,090
27,045,150
29,824,296
CURRENT ASSETS
Stocks
15
11,192,685
12,558,742
Debtors
16
17,374,934
14,985,744
Cash at bank and in hand
3,867
175,328
28,571,486
27,719,814
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
17
(29,879,181)
(40,099,357)
NET CURRENT LIABILITIES
(1,307,695)
(12,379,543)
TOTAL ASSETS LESS CURRENT LIABILITIES
25,737,455
17,444,753
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
18
(11,506,445)
-
PROVISIONS FOR LIABILITIES
Provisions
19
(269,448)
(199,140)
Deferred tax liability
20
36,264
36,264
NET ASSETS
13,997,826
17,281,877
CAPITAL AND RESERVES
Called up share capital
21
20,000,000
20,000,000
Profit and loss reserves
(6,002,174)
(2,718,123)
TOTAL EQUITY
13,997,826
17,281,877

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 11 August 2026 and are signed on its behalf by:
PRAMAC-GENERAC UK LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025
31 December 2025
- 13 -
J  McNally
Director
Company registration number 01432297 (England and Wales)
PRAMAC-GENERAC UK LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 14 -
Share capital
Profit and loss reserves
Total
£
£
£
BALANCE AT 1 JANUARY 2024
20,000,000
917,432
20,917,432
YEAR ENDED 31 DECEMBER 2024:
Loss and total comprehensive income
-
(3,635,555)
(3,635,555)
BALANCE AT 31 DECEMBER 2024
20,000,000
(2,718,123)
17,281,877
YEAR ENDED 31 DECEMBER 2025:
Loss and total comprehensive income
-
(3,284,051)
(3,284,051)
BALANCE AT 31 DECEMBER 2025
20,000,000
(6,002,174)
13,997,826
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 15 -
1
ACCOUNTING POLICIES
Company information

Pramac-Generac UK Limited is a private company limited by shares incorporated in England and Wales. The registered office is Units 3 & 4 Nyfield Business Park, Lawford Road, Rugby, Warwickshire, CV21 2UX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of PR Industrial SRL. These consolidated financial statements are available from its registered office, Localita il Piano, 53031 Casole d'Elsa (SIENA), Italy.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 16 -
1.2
Going concern

At 31 December 2025, the company made a loss before tax of £3,235,473 (2024: £3,782,393) and has net current liabilities of £1,307,695 (2024: 12,379,543). As a result, the directors have had to consider whether the going concern basis is appropriate. Amounts owed to group undertakings of £39,170,445 are due within one year, but the group have stated that they will not demand repayment within one year.true

 

The company does not have any external funding and is supported by a group cash pooling facility to meet its debts as they fall due. The directors have concluded that the company will meet all its liabilities as they fall due and that is appropriate to prepare the accounts on a going concern basis.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (upon delivery goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised 10% straight line basis.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 17 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
5-6% straight line
Plant and equipment
15-33% straight line
Fixtures and fittings
15-33% straight line
Computers
15-33% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 18 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 19 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 20 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.11
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.12
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 21 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.13
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.14
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.15
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.16
Leases
As lessee
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
ACCOUNTING POLICIES
(Continued)
- 22 -

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

As lessor

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

2
JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Valuation of stock provision

The provision is calculated based on movement of stock for a period of 3 years and is classified 4 different categories. Full provision is made for stock if there has been minimal movements for the past 3 years and different rates are applied to the remaining categories. At 31 December 2025, the provision for old stock was £2,898,222 against a total stock value of £14,090,907.

Bad debts provision

The company monitors the risk profile of debtors regularly and makes a provision for amounts that may not be recoverable on the basis of expected loss. When a trade receivable is not collectable it is written off against the bad debt provision. At 31 December 2025, the provision for bad debts was £226,412 against a total debtor balance of £15,472,106.

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
2
JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
(Continued)
- 23 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Impairment of Goodwill

Determining whether goodwill is impaired requires an estimate of the recoverable amount of the cash-generating unit to which it is allocated. This has been assessed on a value-in-use basis, using cash flow projections based on the entity's trading results, forecasts and discounted to present value. The carrying amount of goodwill at the reporting date is £15,870,079. The key assumptions carrying a significant risk of causing a material adjustment within the next financial year are post year-end trading performance, the long-term growth rate, and the discount rate.

Warranty provision

The company provides for the estimated cost of rectifying or replacing products sold that remain within their warranty period. The provision is management's best estimate of the expenditure required to settle the obligation at the reporting date, based on the volume of products under warranty, historical claim and failure rates, and the average cost of rectification. The actual level of claims, and the unit cost of repair or replacement, may differ from these assumptions, and a change in either would materially alter the carrying amount of the provision. At 31 December 2025 the provision recognised was £219,448.

Dilapidation provision

The company is obliged under the terms of its property leases to return the premises to a specified condition at the end of the lease. The provision represents management's best estimate of that cost, the extent of alterations made to each property. These estimates are inherently uncertain because the final cost is only settled on exit and is subject to negotiation with the landlord. At 31 December 2025 the provision recognised was £50,000.

3
TURNOVER AND OTHER REVENUE
2025
2024
£
£
Turnover analysed by class of business
Sale of goods
29,303,538
25,576,083
2025
2024
£
£
Other revenue
Interest income
13,224
7,640
Dividends received
213,225
209,995
Commissions received
66,750
-
0
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 24 -
4
EXCEPTIONAL ITEM
2025
2024
£
£
Income
Exceptional item - Other operating income
1,000,000
-
5
OPERATING LOSS
2025
2024
Operating loss for the year is stated after charging/(crediting):
£
£
Exchange (gains)/losses
(29,635)
28,307
Fees payable to the company's auditor for the audit of the company's financial statements
35,000
32,800
Depreciation of tangible fixed assets
238,468
230,360
(Profit)/loss on disposal of tangible fixed assets
-
786
Amortisation of intangible assets
2,578,759
2,578,759
Impairment of trade debtors
103,993
155,151
Operating lease charges
82,400
69,185
6
EMPLOYEES

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Production staff
8
10
Distribution staff
5
6
Administrative staff
43
41
Total
56
57
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
6
EMPLOYEES
(Continued)
- 25 -

Their aggregate remuneration comprised:

2025
2024
£
£
Wages and salaries
2,423,499
2,679,842
Social security costs
359,742
301,556
Pension costs
-
0
43,189
2,783,241
3,024,587
7
DIRECTORS' REMUNERATION
2025
2024
£
£
Remuneration for qualifying services
22,960
184,242
Company pension contributions to defined contribution schemes
-
43,189
22,960
227,431
8
INTEREST RECEIVABLE AND SIMILAR INCOME
2025
2024
£
£
Interest income
Other interest income
13,224
7,640
Income from fixed asset investments
Income from shares in group undertakings
213,225
209,995
Total income
226,449
217,635
9
INTEREST PAYABLE AND SIMILAR EXPENSES
2025
2024
£
£
Other interest
979,743
781,376
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 26 -
10
TAXATION
2025
2024
£
£
Current tax
Adjustments in respect of prior periods
-
0
(146,812)
Deferred tax
Origination and reversal of timing differences
-
0
(26)
Adjustment in respect of prior periods
48,578
-
0
Total deferred tax
48,578
(26)
Total tax charge/(credit)
48,578
(146,838)

The actual charge/(credit) for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Loss before taxation
(3,235,473)
(3,782,393)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
(808,868)
(945,598)
Tax effect of expenses that are not deductible in determining taxable profit
580,600
596,680
Adjustments in respect of prior years
228,268
(152,139)
Group relief
-
0
341,635
Other non-reversing timing differences
-
0
12,584
Deferred tax adjustments in respect of prior years
48,578
-
0
Taxation charge/(credit) for the year
48,578
(146,838)
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 27 -
11
INTANGIBLE FIXED ASSETS
Goodwill
£
Cost
At 1 January 2025 and 31 December 2025
25,787,588
Amortisation and impairment
At 1 January 2025
7,338,750
Amortisation charged for the year
2,578,759
At 31 December 2025
9,917,509
Carrying amount
At 31 December 2025
15,870,079
At 31 December 2024
18,448,838
12
TANGIBLE FIXED ASSETS
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 January 2025
628,852
332,709
485,831
130,604
102,991
1,680,987
Additions
4,295
24,209
7,967
1,610
-
0
38,081
Disposals
-
0
(44,476)
(109,379)
(63,448)
-
0
(217,303)
At 31 December 2025
633,147
312,442
384,419
68,766
102,991
1,501,765
Depreciation and impairment
At 1 January 2025
75,073
126,033
369,553
100,007
72,953
743,619
Depreciation charged in the year
34,215
68,601
87,278
22,626
25,748
238,468
Eliminated in respect of disposals
-
0
(44,476)
(109,379)
(63,448)
-
0
(217,303)
At 31 December 2025
109,288
150,158
347,452
59,185
98,701
764,784
Carrying amount
At 31 December 2025
523,859
162,284
36,967
9,581
4,290
736,981
At 31 December 2024
553,779
206,676
116,278
30,597
30,038
937,368
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
12
TANGIBLE FIXED ASSETS
(Continued)
- 28 -

The leased asset is held under a lease agreement with a lease term of sixteen years.

13
FIXED ASSET INVESTMENTS
2025
2024
Notes
£
£
Investments in subsidiaries
14
10,438,090
10,438,090
14
SUBSIDIARIES

Details of the company's subsidiaries at 31 December 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Pramac Racing Limited
United Kingdom
Ordinary
50.00
Off Grid Energy Limited
United Kingdom
Ordinary
100.00
15
STOCKS
2025
2024
£
£
Finished goods and goods for resale
11,192,685
12,558,742
16
DEBTORS
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
15,245,693
11,027,358
Corporation tax recoverable
242,645
239,219
Amounts owed by group undertakings
1,384,645
3,384,081
Other debtors
56,194
8,966
Prepayments and accrued income
445,757
326,120
17,374,934
14,985,744
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 29 -
17
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025
2024
£
£
Trade creditors
262,453
814,863
Amounts owed to group undertakings
27,685,299
35,311,763
Taxation and social security
972,850
1,649,961
Other creditors
340,222
1,159,467
Accruals and deferred income
618,357
1,163,303
29,879,181
40,099,357
18
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025
2024
£
£
Amounts owed to group undertakings
11,506,445
-
0
19
PROVISIONS FOR LIABILITIES
2025
2024
£
£
Warranty provision
219,448
149,140
Dilapidation provision
50,000
50,000
269,448
199,140
Movements on provisions:
Warranty provision
Dilapidation provision
Total
£
£
£
At 1 January 2025
149,140
50,000
199,140
Additional provisions in the year
70,308
-
70,308
At 31 December 2025
219,448
50,000
269,448
PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 30 -
20
DEFERRED TAXATION

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
(36,264)
(36,264)
There were no deferred tax movements in the year.

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

21
SHARE CAPITAL
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
20,000,000
20,000,000
20,000,000
20,000,000
22
OPERATING LEASE COMMITMENTS
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2025
2024
£
£
Within 1 year
724,449
688,948
Years 2-5
2,225,590
2,202,008
After 5 years
-
0
407,225
2,950,039
3,298,181
As lessor - operating leases

 

PRAMAC-GENERAC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
22
OPERATING LEASE COMMITMENTS
(Continued)
- 31 -
2025
2024
Amounts recognised in profit or loss:
£
£
Total lease income
213,535
309,159
Including the following:
23
ULTIMATE CONTROLLING PARTY

In the directors opinion the company's ultimate parent undertaking is Generac Holdings Inc., which is incorporated in USA.

 

The parent undertaking of the smallest group which includes the company for which group financial statements are prepared is PR Industrial S.r.l. Copies of its group financial statements, which include the company, are available from Localita il Piano, 53031 Casole d'Elsa (SIENA) Italy.

 

The parent undertaking of the largest group which includes the company for which group financial statements are prepared is Generac Holdings Inc. Copies of its group financial statements, which include the company, are available from www.generac.com.

24
POST BALANCE SHEET EVENT

In January 2026, the shares previously held by the company in Pramac Racing Limited were transferred to BF Management & Consulting Ltd, resulting in BF Management & Consulting Ltd obtaining full control of the subsidiary.

 

As these events occurred after the reporting date of 31 December 2025, they are considered non-adjusting post balance sheet events. Accordingly, no adjustments have been made to the amounts recognised in the financial statements for the year ended 31 December 2025.

2025-12-312025-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100P CampinotiN PagliaiP VerriereMr J J WrightN BorracchiniN BorracchiniJ McNallyA RossiMr A N Coughlan014322972025-01-012025-12-3101432297bus:Director32025-01-012025-12-3101432297bus:Director62025-01-012025-12-3101432297bus:Director72025-01-012025-12-3101432297bus:Director82025-01-012025-12-3101432297bus:CompanySecretary12025-01-012025-12-3101432297bus:Director12025-01-012025-12-3101432297bus:Director22025-01-012025-12-3101432297bus:Director42025-01-012025-12-3101432297bus:Director52025-01-012025-12-3101432297bus:RegisteredOffice2025-01-012025-12-31014322972025-12-31014322972024-01-012024-12-3101432297core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3101432297core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3101432297core:Goodwill2025-12-3101432297core:Goodwill2024-12-31014322972024-12-3101432297core:LeaseholdImprovements2025-12-3101432297core:PlantMachinery2025-12-3101432297core:FurnitureFittings2025-12-3101432297core:ComputerEquipment2025-12-3101432297core:MotorVehicles2025-12-3101432297core:LeaseholdImprovements2024-12-3101432297core:PlantMachinery2024-12-3101432297core:FurnitureFittings2024-12-3101432297core:ComputerEquipment2024-12-3101432297core:MotorVehicles2024-12-31014322972024-12-3101432297core:ShareCapital2025-12-3101432297core:ShareCapital2024-12-3101432297core:RetainedEarningsAccumulatedLosses2025-12-3101432297core:RetainedEarningsAccumulatedLosses2024-12-3101432297core:ShareCapital2023-12-3101432297core:RetainedEarningsAccumulatedLosses2023-12-3101432297core:ShareCapitalOrdinaryShareClass12025-12-3101432297core:ShareCapitalOrdinaryShareClass12024-12-3101432297core:Goodwill2025-01-012025-12-3101432297core:LeaseholdImprovements2025-01-012025-12-3101432297core:PlantMachinery2025-01-012025-12-3101432297core:FurnitureFittings2025-01-012025-12-3101432297core:ComputerEquipment2025-01-012025-12-3101432297core:MotorVehicles2025-01-012025-12-310143229712025-01-012025-12-310143229712024-01-012024-12-3101432297core:UKTax2025-01-012025-12-3101432297core:UKTax2024-01-012024-12-3101432297core:Goodwill2024-12-3101432297core:LeaseholdImprovements2024-12-3101432297core:PlantMachinery2024-12-3101432297core:FurnitureFittings2024-12-3101432297core:ComputerEquipment2024-12-3101432297core:MotorVehicles2024-12-3101432297core:Non-currentFinancialInstruments2025-12-3101432297core:Non-currentFinancialInstruments2024-12-3101432297core:Subsidiary12025-01-012025-12-3101432297core:Subsidiary22025-01-012025-12-3101432297core:Subsidiary112025-01-012025-12-3101432297core:Subsidiary222025-01-012025-12-3101432297core:CurrentFinancialInstruments2025-12-3101432297core:CurrentFinancialInstruments2024-12-3101432297core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3101432297core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3101432297bus:OrdinaryShareClass12025-01-012025-12-3101432297bus:OrdinaryShareClass12025-12-3101432297bus:OrdinaryShareClass12024-12-3101432297core:WithinOneYear2025-12-3101432297core:WithinOneYear2024-12-3101432297core:BetweenTwoFiveYears2025-12-3101432297core:BetweenTwoFiveYears2024-12-3101432297core:MoreThanFiveYears2025-12-3101432297core:MoreThanFiveYears2024-12-3101432297bus:PrivateLimitedCompanyLtd2025-01-012025-12-3101432297bus:FRS1022025-01-012025-12-3101432297bus:Audited2025-01-012025-12-3101432297bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP